Brief: Ryvu Therapeutics Q3 Net Loss Narrows To 11.8 Mln Zlotys
Nov 23 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q3 NET LOSS OF 11.8 MILLION ZLOTYS VERSUS LOSS OF 22.8
MILLION
ZLOTYS YEAR AGO
* Q3 OPERATING REVENUE 19.7 MILLION ZLOTYS VERSUS 7.0
MILLION
ZLOTYS YEAR AGO
* Q3 OPERATING LOSS OF 12.9 MILLION ZLOTYS VERSUS LOSS OF
22.9
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM73rdPZa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys